Tzu Chi Medical Journal最新文献

筛选
英文 中文
The obesity paradox exists in Asia: A systematic review and meta-analysis of body mass index effects on clinical outcomes following percutaneous coronary intervention in Asia. 亚洲存在肥胖悖论:亚洲经皮冠状动脉介入治疗后体重指数对临床结果影响的系统回顾和荟萃分析。
IF 1.4
Tzu Chi Medical Journal Pub Date : 2024-09-05 eCollection Date: 2024-10-01 DOI: 10.4103/tcmj.tcmj_317_23
Andrianto, Chabib Fachry Albab, Nandha Pratama Mahardika
{"title":"The obesity paradox exists in Asia: A systematic review and meta-analysis of body mass index effects on clinical outcomes following percutaneous coronary intervention in Asia.","authors":"Andrianto, Chabib Fachry Albab, Nandha Pratama Mahardika","doi":"10.4103/tcmj.tcmj_317_23","DOIUrl":"https://doi.org/10.4103/tcmj.tcmj_317_23","url":null,"abstract":"<p><p>Cardiovascular diseases (CVDs) are major contributors to illness and death globally. Body mass index (BMI) is a well-established prognostic factor on cardiovascular risk outcome. Numerous investigations have provided evidence for the existence of the obesity paradox after percutaneous coronary intervention (PCI). However, the association between BMI and the results following PCI has not been extensively investigated in Asian populations. The research aims to fill the current void in understanding by investigating the association between BMI and clinical consequences following PCI, with a particular focus on Asian individuals. A systematic search was conducted through PubMed, ScienceDirect, and Cochrane Library to identify studies examining the effect of BMI on clinical outcome after PCI in Asia. R Studio 4.3.2 software was used to carry out the analysis of the data. A total of 182,110 patients who had gone through PCI were found in the 5 included cohorts. A meta-analysis conducted on the subjects revealed that patients who were overweight (odds ratio [OR] = 0.60, 95% confidence interval [CI] [0.57, 0.63], <i>P</i> < 0.0001) had a lower risk of all-cause mortality compared to individuals with a healthy weight and patients with obesity (OR = 0.65, 95% CI [0.41, 1.05], <i>P</i> = 0.006) had a lower risk of all-cause mortality than healthy weight individuals. The study also found that overweight patients (OR = 0.60, 95% CI [0.39, 0.91], <i>P</i> = 0.02) had a lower risk of cardiac mortality. In addition, obese patients (OR = 0.41, 95% CI [0.19, 0.88], <i>P</i> = 0.02) had a lower risk of noncardiac mortality. However, the study found that there were no differences in major adverse cardiovascular event, myocardial infarction, and bleeding between all patient groups. This meta-analysis supports the presence of an obesity paradox after PCI in Asian populations. The obesity paradox was evident in all-cause mortality, cardiac mortality, and noncardiac mortality.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":"36 4","pages":"387-395"},"PeriodicalIF":1.4,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11483094/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142477329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The value of 18F-fluorodeoxyglucose positron emission tomography-based radiomics in non-small cell lung cancer. 基于18f -氟脱氧葡萄糖正电子发射层析成像的放射组学在非小细胞肺癌中的价值。
IF 1.4
Tzu Chi Medical Journal Pub Date : 2024-09-03 eCollection Date: 2025-01-01 DOI: 10.4103/tcmj.tcmj_124_24
Yu-Hung Chen, Kun-Han Lue, Sung-Chao Chu, Chih-Bin Lin, Shu-Hsin Liu
{"title":"The value of <sup>18</sup>F-fluorodeoxyglucose positron emission tomography-based radiomics in non-small cell lung cancer.","authors":"Yu-Hung Chen, Kun-Han Lue, Sung-Chao Chu, Chih-Bin Lin, Shu-Hsin Liu","doi":"10.4103/tcmj.tcmj_124_24","DOIUrl":"10.4103/tcmj.tcmj_124_24","url":null,"abstract":"<p><p>Currently, the second most commonly diagnosed cancer in the world is lung cancer, and 85% of cases are non-small cell lung cancer (NSCLC). With growing knowledge of oncogene drivers and cancer immunology, several novel therapeutics have emerged to improve the prognostic outcomes of NSCLC. However, treatment outcomes remain diverse, and an accurate tool to achieve precision medicine is an unmet need. Radiomics, a method of extracting medical imaging features, is promising for precision medicine. Among all radiomic tools, <sup>18</sup>F-fluorodeoxyglucose positron emission tomography (<sup>18</sup>F-FDG PET)-based radiomics provides distinct information on glycolytic activity and heterogeneity. In this review, we collected relevant literature from PubMed and summarized the various applications of <sup>18</sup>F-FDG PET-derived radiomics in improving the detection of metastasis, subtyping histopathologies, characterizing driver mutations, assessing treatment response, and evaluating survival outcomes of NSCLC. Furthermore, we reviewed the values of <sup>18</sup>F-FDG PET-based deep learning. Finally, several challenges and caveats exist in the implementation of <sup>18</sup>F-FDG PET-based radiomics for NSCLC. Implementing <sup>18</sup>F-FDG PET-based radiomics in clinical practice is necessary to ensure reproducibility. Moreover, basic studies elucidating the underlying biological significance of <sup>18</sup>F-FDG PET-based radiomics are lacking. Current inadequacies hamper immediate clinical adoption; however, radiomic studies are progressively addressing these issues. <sup>18</sup>F-FDG PET-based radiomics remains an invaluable and indispensable aspect of precision medicine for NSCLC.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":"37 1","pages":"17-27"},"PeriodicalIF":1.4,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11753514/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143029920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of leukocyte depletion of packed red blood cells for the prevention of clinically observed transfusion reactions at a medical center in Eastern Taiwan. 在台湾东部某医疗中心,白血球耗尽对预防输血反应之评估。
IF 1.4
Tzu Chi Medical Journal Pub Date : 2024-09-03 eCollection Date: 2025-01-01 DOI: 10.4103/tcmj.tcmj_47_24
Kai-Yun Su, Jing-Chun Huang, Jing-Yi Lin, Chun-Chun Chang
{"title":"Evaluation of leukocyte depletion of packed red blood cells for the prevention of clinically observed transfusion reactions at a medical center in Eastern Taiwan.","authors":"Kai-Yun Su, Jing-Chun Huang, Jing-Yi Lin, Chun-Chun Chang","doi":"10.4103/tcmj.tcmj_47_24","DOIUrl":"10.4103/tcmj.tcmj_47_24","url":null,"abstract":"<p><strong>Objectives: </strong>The incidence of febrile nonhemolytic transfusion reactions (FNHTRs) is correlated with the level of cytokines released by donor leukocytes in blood bags during storage, which is the most common transfusion reaction. The study aimed to reveal whether the use of leukocyte-poor red blood cells (LPRBCs) can reduce the incidence of transfusion reactions to promote patient safety.</p><p><strong>Materials and methods: </strong>From January 2014 to June 2022, 158,122 blood transfusion reports were collected from a medical center in Eastern Taiwan. Data were categorized into three groups according to usage: prepromotion use of LPRBCs (January 2014-April 2016), promotion use of LPRBCs (May 2016 to February 2018), and full utilization of LPRBCs (March 2018 to June 2022). According to the American Association of Blood Bank Common Transfusion Reaction Reporting Form version 2.0 reporting system, FNHTRs were classified as moderate transfusion reactions. We used these data to analyze the association between LPRBC use and transfusion reaction rate.</p><p><strong>Results: </strong>At our hospital, the LPRBC usage rate from January 2014 to April 2016, May 2016 to February 2018, and March 2018 to June 2022 was 5.37%, 34.82%, and 56.45%, respectively. The total transfusion reaction rate from January 2014 to April 2016 was 1.66%, whereas the moderate reaction rate was 1.29%. The total transfusion and moderate reaction rates from May 2016 to February 2018 were 1.41% and 1.00%, whereas those from March 2018 to June 2022 were 0.95% and 0.63%, respectively. The total transfusion and moderate reaction rates from March 2018 to June 2022 decreased by 42.8% and 51.2%, respectively, compared with those from January 2014 to April 2016. We further compared the incidence of transfusion reactions caused by packed red blood cells (PRBC) and LPRBC products in different years. The results showed that between 2014 and 2022, the types of blood transfusion reaction caused using PRBC and LPRBC products are the mild transfusion reaction rate of 0.20%/0.20%, the moderate transfusion reaction rate of 1.61%/0.69%, the severe transfusion reaction rates 0.38%/0.16%, and the total transfusion reaction rates 2.19%/1.05%.</p><p><strong>Conclusion: </strong>Our study results indicate that both total transfusion and moderate reaction rates significantly decreased with increasing LPRBC usage rate. Based on our data analysis, LPRBC is more effective in reducing moderate and severe transfusion reactions than PRBC.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":"37 1","pages":"109-115"},"PeriodicalIF":1.4,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11753523/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143029806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Roles of endoplasmic reticulum stress and activating transcription factors in Alzheimer's disease and Parkinson's disease. 内质网应激和激活转录因子在阿尔茨海默病和帕金森病中的作用。
IF 1.4
Tzu Chi Medical Journal Pub Date : 2024-08-28 eCollection Date: 2025-01-01 DOI: 10.4103/tcmj.tcmj_51_24
Ching-Feng Cheng, Evelyn Cheng, Hui-Chen Ku
{"title":"Roles of endoplasmic reticulum stress and activating transcription factors in Alzheimer's disease and Parkinson's disease.","authors":"Ching-Feng Cheng, Evelyn Cheng, Hui-Chen Ku","doi":"10.4103/tcmj.tcmj_51_24","DOIUrl":"10.4103/tcmj.tcmj_51_24","url":null,"abstract":"<p><p>Endoplasmic reticulum (ER) is a crucial organelle associated with cellular homeostasis. Accumulation of improperly folded proteins results in ER stress, accompanied by the reaction involving triggering unfolded protein response (UPR). The UPR is mediated through ER membrane-associated sensors, such as protein kinase-like ER kinase (PERK), inositol-requiring transmembrane kinase/endoribonuclease 1α, and activating transcription factor 6 (ATF6). Prolonged stress triggers cell apoptotic reaction, resulting in cell death. Neuronal cells are especially susceptible to protein misfolding. Notably, ER and UPR malfunctions are linked to many neurodegenerative diseases, such as Alzheimer's disease (AD) and Parkinson's disease (PD), delineated by accumulation of misfolded proteins. Notably, ATF family members play key roles in AD and PD pathogenesis. However, the connection between ER stress, UPR, and neuropathology is not yet fully understood. Here, we discuss our present knowledge of the association between ER stress, the UPR, and neurodegeneration in AD and PD. We also discuss the roles of ATF family members in AD and PD pathogenesis. Moreover, we provide a mechanistic clarification of how disease-related molecules affect ER protein homeostasis and explore recent findings that connect the UPR to neuronal plasticity.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":"37 1","pages":"10-16"},"PeriodicalIF":1.4,"publicationDate":"2024-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11753521/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143029938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of netrin G1-netrin-G-ligand-1 in schizophrenia. netrin g1 -netrin- g配体-1在精神分裂症中的作用。
IF 1.4
Tzu Chi Medical Journal Pub Date : 2024-08-22 eCollection Date: 2025-01-01 DOI: 10.4103/tcmj.tcmj_83_24
Ayooluwa Gabriel Ibiayo, Luo-Zhu Yang, Ingrid Y Liu
{"title":"The role of netrin G1-netrin-G-ligand-1 in schizophrenia.","authors":"Ayooluwa Gabriel Ibiayo, Luo-Zhu Yang, Ingrid Y Liu","doi":"10.4103/tcmj.tcmj_83_24","DOIUrl":"10.4103/tcmj.tcmj_83_24","url":null,"abstract":"<p><p>Schizophrenia (SCZ) is a chronic psychotic disorder that profoundly alters an individual's perception of reality, resulting in abnormal behavior, cognitive deficits, thought distortions, and disorientation in emotions. Many complicated factors can lead to SCZ, and investigations are ongoing to understand the neurobiological underpinnings of this condition. Presynaptic Netrin G1 and its cognate partner postsynaptic Netrin-G-Ligand-1 (NGL-1) have been implicated in SCZ. This review article emphasized the structure and expression of Netrin G1/NGL-1 in the brain, its dysregulation in SCZ patients, and its role in synaptic plasticity, synaptic interaction, learning and memory, microglia neurotrophic activity, and possible signaling between Netrin G1/NGL-1, postsynaptic density protein 95, and cyclin-dependent kinase-like 5 in synaptic morphogenesis. Pharmaceutical targets and the potential use of Netrin G1/NGL-1 as treatment targets or biomarkers for SCZ were also discussed.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":"37 1","pages":"1-9"},"PeriodicalIF":1.4,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11753516/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143029992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of fibrin sealant in drain-free transoral endoscopic thyroidectomy vestibular approach. 纤维蛋白密封胶在经口内窥镜前庭入路甲状腺切除术中的应用。
IF 1.4
Tzu Chi Medical Journal Pub Date : 2024-08-19 eCollection Date: 2025-01-01 DOI: 10.4103/tcmj.tcmj_41_24
Wei-Chieh Lin, Ciou-Nan Ye, Chung-Ching Lin, Pornpeera Jitpratoom, Hung-Pin Wu, Yi-Fan Chou
{"title":"Application of fibrin sealant in drain-free transoral endoscopic thyroidectomy vestibular approach.","authors":"Wei-Chieh Lin, Ciou-Nan Ye, Chung-Ching Lin, Pornpeera Jitpratoom, Hung-Pin Wu, Yi-Fan Chou","doi":"10.4103/tcmj.tcmj_41_24","DOIUrl":"10.4103/tcmj.tcmj_41_24","url":null,"abstract":"<p><strong>Objective: </strong>The transoral endoscopic thyroidectomy vestibular approach (TOETVA) is a minimally invasive technique. This study aimed to compare the safety of TOETVA with fibrin sealant (Tisseel) and TOETVA with drainage.</p><p><strong>Materials and methods: </strong>Patients who underwent TOETVA between January 2018 and December 2021 were divided into drainage (<i>n</i> = 20) and Tisseel (<i>n</i> = 30) groups.</p><p><strong>Results: </strong>The primary outcome was the incidence of complications. The secondary outcomes were operative time and postoperative pain. There were no significant differences in patient demographics, tumor size, intraoperative blood loss, and hospitalization days between the two groups. No patient required conversion to open thyroidectomy. The incidence of complications and postoperative pain was similar in the two groups. The operative time for TOETVA with Tisseel was significantly shorter than for TOETVA with drainage (<i>P</i> = 0.038).</p><p><strong>Conclusion: </strong>TOETVA with Tisseel is a safe alternative to TOETVA with drainage, having a short operative time.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":"37 1","pages":"86-90"},"PeriodicalIF":1.4,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11753525/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143029703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and efficacy of stent-assisted coiling ruptured intracranial aneurysms: A single-center experience. 支架辅助盘绕破裂颅内动脉瘤的安全性和有效性:单中心研究。
IF 1.4
Tzu Chi Medical Journal Pub Date : 2024-08-12 eCollection Date: 2025-04-01 DOI: 10.4103/tcmj.tcmj_92_24
Deng-Xiang Zhang, Chao-Bao Luo, Chien-Hui Lee
{"title":"Safety and efficacy of stent-assisted coiling ruptured intracranial aneurysms: A single-center experience.","authors":"Deng-Xiang Zhang, Chao-Bao Luo, Chien-Hui Lee","doi":"10.4103/tcmj.tcmj_92_24","DOIUrl":"https://doi.org/10.4103/tcmj.tcmj_92_24","url":null,"abstract":"<p><strong>Objectives: </strong>Endovascular coiling is a minimally invasive method to manage intracranial aneurysms. However, patients who undergo stent-assisted coiling (SAC) for acutely ruptured intracranial aneurysms need dual antiplatelet treatment. We reported our experience and outcomes of SAC for ruptured intracranial aneurysm.</p><p><strong>Materials and methods: </strong>We retrospectively collected data on procedure-related complications, rates of aneurysm rebleeding and recurrence, and clinical outcomes of patients with ruptured aneurysms managed by SAC over 2 years.</p><p><strong>Results: </strong>Among the 17 patients included in this study, there were 14 (82.4%) women and 3 (17.6%) men, with a mean age of 58.59 years (standard deviation = 13.57; range: 40-82 years). There were no periprocedural hemorrhagic complications and no aneurysm rebleeding before discharge. However, two patients developed acute brain infarction because of symptomatic vasospasm. Linear regression revealed significant associations of posterior circulation involvement with the Glasgow Outcome Score and modified Rankin Scale (mRS) at discharge and 6 months after. Besides, Hunt and Hess grade ≥3 has a significant association with mRS at discharge, 6 months, and 1 year after.</p><p><strong>Conclusion: </strong>SAC for ruptured aneurysm was technically feasible and did not carry an additional risk of postoperative aneurysm rebleeding secondary to antiplatelet treatment. Moreover, it had relatively low rates of aneurysm regrowth and coil compaction. Therefore, it can be a safe and effective endovascular treatment for acutely ruptured intracranial aneurysm.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":"37 2","pages":"189-197"},"PeriodicalIF":1.4,"publicationDate":"2024-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12048123/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143990936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nocturia, nocturnal polyuria, and nocturnal enuresis in adults: What we know and what we do not know. 成人夜尿症、夜间多尿症和夜间遗尿症:我们知道什么,我们不知道什么。
IF 1.4
Tzu Chi Medical Journal Pub Date : 2024-05-27 eCollection Date: 2024-10-01 DOI: 10.4103/tcmj.tcmj_53_24
Tien-Lin Chang, Hann-Chorng Kuo
{"title":"Nocturia, nocturnal polyuria, and nocturnal enuresis in adults: What we know and what we do not know.","authors":"Tien-Lin Chang, Hann-Chorng Kuo","doi":"10.4103/tcmj.tcmj_53_24","DOIUrl":"https://doi.org/10.4103/tcmj.tcmj_53_24","url":null,"abstract":"<p><p>Nocturia is defined as the nocturnal frequency of one or more voiding episodes per night. It increases with aging and has an impact on sleep quality and the risks of falling and mortality. Nocturia disorder involves nighttime frequency, nocturnal polyuria, and nocturnal enuresis. In older adults with nocturia disorder, multiple factors could contribute to nocturia severity and characteristics, including poor sleep quality, lower urinary tract dysfunction, and excessive fluid output. Several nonurological medical diseases have been found to result in nocturia, such as hypertension, congestive heart failure, chronic kidney disease, chronic obstructive pulmonary disease, metabolic syndrome, and diabetes. Urological and medical assessments should be performed to diagnose nocturia disorder. A frequency volume chart to evaluate the nocturnal polyuria index, functional bladder capacity, and urodynamic study can reveal the presence of nocturnal polyuria and lower urinary tract dysfunction. Treatment should be based on multiple nocturia etiologies, and a combination of multiple therapies for individual pathophysiology will achieve a better treatment outcome.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":"36 4","pages":"370-376"},"PeriodicalIF":1.4,"publicationDate":"2024-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11483088/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142477328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Do urinary tract infections affect the rate of periprosthetic joint infections in patients who underwent arthroplasty surgery? A systematic review and meta-analysis. 尿路感染会影响接受关节置换手术患者的假体周围关节感染率吗?系统回顾和荟萃分析。
IF 1.4
Tzu Chi Medical Journal Pub Date : 2024-05-27 eCollection Date: 2024-07-01 DOI: 10.4103/tcmj.tcmj_309_23
Antoninus Hengky, Malvin Tandry, Kevin Gracia Pratama, Pauliana Pauliana, Christopher Kusumajaya, Astrawinata Guatama
{"title":"Do urinary tract infections affect the rate of periprosthetic joint infections in patients who underwent arthroplasty surgery? A systematic review and meta-analysis.","authors":"Antoninus Hengky, Malvin Tandry, Kevin Gracia Pratama, Pauliana Pauliana, Christopher Kusumajaya, Astrawinata Guatama","doi":"10.4103/tcmj.tcmj_309_23","DOIUrl":"10.4103/tcmj.tcmj_309_23","url":null,"abstract":"<p><p>Periprosthetic joint infection (PJI) is a significant issue in orthopedic surgery. Urinary tract infections (UTIs) and asymptomatic bacteriuria (ASB) have been identified as potential causes of PJI; however, evidence is inconclusive. Understanding these relationships is critical for improving therapy and patient outcomes. A systematic review was performed by conducting searches from PubMed, EBSCO, ProQuest, and manual searching with adherence to the Preferred Reporting Items for Systematic Review and Meta-Analysis 2020 guideline. Studies that reported UTI/ASB and PJI were included. Meta-analysis was conducted using a random-effects model using RevMan 5.4 software. A total of 14 studies were included with UTIs and ASB showed an overall association with increased risk of PJI (odds ratio [OR]: 1.84, 95% confidence interval [CI]: 1.14-2.99, <i>P</i> = 0.01). However, subgroup analysis for UTIs and ASB was not significant. Further analysis of UTIs in total hip arthroplasty (THA) surgery showed a significant association (OR: 1.76, 95% CI: 1.57-1.96) with PJI. Preoperative UTIs timing between 0 and 2 weeks before surgery showed an increased risk of PJI (OR: 1.45, 95% CI: 1.35-1.55). Antibiotic treatment in ASB did not significantly impact PJI rates. Urine and PJI sample cultures in four studies showed no correlation of microorganisms between the two sites. According to recent evidence, a statistically significant association was found between UTIs and PJI in patients who underwent THA surgery. However, ASB did not yield significant results in relation to PJI. These results should be supported by larger and well-designed studies to make proper clinical suggestion in future. For further research, it is recommended to adopt standardized criteria for outcome measurement and to involve larger sample sizes to enhance the reliability and generalizability of findings.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":"36 3","pages":"275-283"},"PeriodicalIF":1.4,"publicationDate":"2024-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11236074/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141591674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
C-X-C motif chemokine ligand 12-C-X-C chemokine receptor type 4 signaling axis in cancer and the development of chemotherapeutic molecules. 癌症中的 C-X-C motif 趋化因子配体 12-C-X-C 趋化因子受体 4 型信号轴与化疗分子的开发。
IF 1.4
Tzu Chi Medical Journal Pub Date : 2024-05-27 eCollection Date: 2024-07-01 DOI: 10.4103/tcmj.tcmj_52_24
Jui-Hung Yen, Chun-Chun Chang, Hao-Jen Hsu, Chin-Hao Yang, Hemalatha Mani, Je-Wen Liou
{"title":"C-X-C motif chemokine ligand 12-C-X-C chemokine receptor type 4 signaling axis in cancer and the development of chemotherapeutic molecules.","authors":"Jui-Hung Yen, Chun-Chun Chang, Hao-Jen Hsu, Chin-Hao Yang, Hemalatha Mani, Je-Wen Liou","doi":"10.4103/tcmj.tcmj_52_24","DOIUrl":"10.4103/tcmj.tcmj_52_24","url":null,"abstract":"<p><p>Chemokines are small, secreted cytokines crucial in the regulation of a variety of cell functions. The binding of chemokine C-X-C motif chemokine ligand 12 (CXCL12) (stromal cell-derived factor 1) to a G-protein-coupled receptor C-X-C chemokine receptor type 4 (CXCR4) triggers downstream signaling pathways with effects on cell survival, proliferation, chemotaxis, migration, and gene expression. Intensive and extensive investigations have provided evidence suggesting that the CXCL12-CXCR4 axis plays a pivotal role in tumor development, survival, angiogenesis, metastasis, as well as in creating tumor microenvironment, thus implying that this axis is a potential target for the development of cancer therapies. The structures of CXCL12 and CXCR4 have been resolved with experimental methods such as X-ray crystallography, NMR, or cryo-EM. Therefore, it is possible to apply structure-based computational approaches to discover, design, and modify therapeutic molecules for cancer treatments. Here, we summarize the current understanding of the roles played by the CXCL12-CXCR4 signaling axis in cellular functions linking to cancer progression and metastasis. This review also provides an introduction to protein structures of CXCL12 and CXCR4 and the application of computer simulation and analysis in understanding CXCR4 activation and antagonist binding. Furthermore, examples of strategies and current progress in CXCL12-CXCR4 axis-targeted development of therapeutic anticancer inhibitors are discussed.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":"36 3","pages":"231-239"},"PeriodicalIF":1.4,"publicationDate":"2024-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11236080/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141591673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信